Member Info for sir_digby

@b2hs2l, absolutely concur.

Half of yesterday's posts deleted because people can't help getting personal. If your position is so weak that you have to resort to insults then you should probably keep your thoughts to yourself otherwise you're just wasting your time at the keyboard.

AGM in 2 weeks, take your frustrations out on those who deserve it.

China to begin monkey pox screening for all travellers entering the country.

https://t.co/qwuWvBVe4G

Repeating the mistakes of January 2020 when they said covid posed no threat then they had to back peddle weeks later. More cases reported yesterday than in the entirety of May.

CDC finally starts taking MPX seriously, after the horse bolted

https://t.co/kYIuPw1b52

@poidster, if people think ba.5 is going to cause issues then they should check out be.1. Massive growth advantage over ba.5 in Europe. It's mutating now quicker than they can name it but that's going to happen with a pathogen as transmissible as measles and no mitigation or surveillance. This strategy (if you can call it one) isn't working. It isn't attenuating, ba.5 has reverted to attacking the lungs much like delta but far more transmissible.

I currently know an unholy number of people with it right now, many reinfected.

I believe it will need an emergency use listing with WHO, not sure whether a CE mark is required for that. What I do know is that WHO have been promising to supply poorer countries with monkey pox assays WHEN they became available.

Good news on the two assays, there's a serious danger of MPX becoming endemic outside of Africa largely due to a lack of diagnostics and slow response from governments. If you don't belong to a vary narrow subset of the population then you can't get tested at the moment, all testing currently being done at PD. The US has been abysmal in their response.

Meanwhile covid will do covid regardless of what's posted here, 1155 hospitalizations reported in England today.

https://t.co/1UGAV45Ifi

@bullraider, This test demonstrated a sensitivity of 90.1% and specificity of 99.3% from 303 clinical samples.

A lot was made previously of the 'low' sensitivity when it was originally launched compared to other LFTs which have now subsequently been found to fail cdta despite their claims of world beating sensitivity based on small sample sizes.

It was rnsd 1 June.

I have to disagree poidster, it's definitely seasonal, every season.

Not remotely surprised they couldn't get 20% and cancelled the AGM, the board are weak as p@ss without institutional support (entirely their fault and their problem to fix but they didn't take the hint last year). No pi is going to be motivated to vote through resolutions which enrich the board while the SP performs so abysmally, apathy is the natural outcome and it's fully deserved.

Meanwhile, Monkeypox cases up 219 in the UK to 793 (world beating once again) and covid cases/hospitalizations up. WHO are promising monkey pox assays soon to poorer nations, fingers crossed the board get their fingers out and it's ours they're going to be supplying. Instead of tweeting about this sh@t they need to start delivering on it.

20% increase in reported cases today and cases doubled globally in a week.

https://twitter.com/Antonio_Caramia/status/1538075777467654144?t=sh0gUkOs8X4Huvj_nrx-_A&s=19

That's what the F41 adenovirus assay is being developed for, linked to paediatric hepatitis.

Wakefield notably didn't buy any shares wth the other directors, perhaps he's going to do us a favour and toddle off. Waste of oxygen.

From Bloomberg, likely explains why they've only found 70 cases in the US. There'll be far more undiagnosed.

https://t.co/j0ORal1pst

They already can purchase shares, it's exactly the same resolution as last year. They haven't bought back a single share.

They should do it, hold them in treasury and use them at a future date and significantly higher SP for an acquisition. They're doing nothing else with the cash. Imo.

It's a familiar old story now. Perhaps we shouldn't have delivered anything at all, meanwhile the government is also going to torch £4bn worth of PPE.

https://www.biopharma-reporter.com/Article/2022/06/16/valneva-reaches-settlement-with-uk-government-over-covid-19-vaccine

No hamster18, the 81m is in addition to money's already received. We're not offering any money back. IMHO

If we aren't quorate at the first time of asking I suspect they might ditch the pay increment resolution, assuming they have even a modicum of self awareness (which you could argue they don't as the resolution is there in the first place). Did they give their rank and file a 10% pay rise? Some how I don't think they did so why the f*** should they be rewarded with one for abject failure.

This would be all so simple for them if they had a raft of IIs instead of ****y PIs to vote through whatever they put on the table, they don't though so they'll have to dance with the one who brought them. I didn't vote for the increment last year, won't be doing it this year either. Will abstain in the hope they aren't quorate and have a rethink.

As it stands, all testing for MPX is currently being carried out at porton down with specimens having to be transported there in the absence of a commercially available assay for use in local labs. The issue of how long it's taking to confirm positives will be impacting contact tracing allowing further community transmission, likely one of the reasons why we aren't getting on top of this outbreak.